Chemical formula: C₂₆H₂₆F₃N₃O₃ Molecular mass: 485.507 g/mol PubChem compound: 24775005
Sonidegib is indicated for:
Population group: only adults (18 years old or older)
Sonidegib is indicated for the treatment of adult patients with locally advanced basal cell carcinoma (BCC) who are not amenable to curative surgery or radiation therapy.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Sonidegib is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
